HGHYX vs. FBTAX

Last updated Jun 3, 2026

HGHYX (The Hartford Healthcare Fund) and FBTAX (Fidelity Advisor Biotechnology Fund Class A) are both Health & Biotech Equities funds. Over the past 10 years, HGHYX returned 8.64%/yr vs 10.51%/yr for FBTAX. Their correlation of 0.83 suggests significant overlap in exposure. Both charge a 1.00% expense ratio.

Performance

HGHYX vs. FBTAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Hartford Healthcare Fund (HGHYX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HGHYX achieves a -3.39% return, which is significantly lower than FBTAX's -0.83% return. Over the past 10 years, HGHYX has underperformed FBTAX with an annualized return of 8.64%, while FBTAX has yielded a comparatively higher 10.51% annualized return.

HGHYX

• 1D: -1.36%
• 1M: 1.10%
• YTD: -3.39%
• 6M: -2.02%
• 1Y: 19.25%
• 3Y*: 5.25%
• 5Y*: 2.14%
• 10Y*: 8.64%

FBTAX

• 1D: -3.05%
• 1M: -5.57%
• YTD: -0.83%
• 6M: -4.16%
• 1Y: 44.32%
• 3Y*: 16.99%
• 5Y*: 9.26%
• 10Y*: 10.51%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HGHYX vs. FBTAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HGHYX The Hartford Healthcare Fund	-3.39%	15.95%	0.23%	4.04%	-11.48%	10.24%	23.07%	41.54%	-2.81%	22.09%
FBTAX Fidelity Advisor Biotechnology Fund Class A	-0.83%	39.54%	5.37%	10.70%	-7.95%	-3.10%	32.17%	25.74%	-3.86%	25.80%

Correlation

The correlation between HGHYX and FBTAX is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.71
Correlation (3Y) Calculated over the trailing 3-year period	0.74
Correlation (5Y) Calculated over the trailing 5-year period	0.75
Correlation (10Y) Calculated over the trailing 10-year period	0.80
Correlation (All Time) Calculated using the full available price history since Dec 28, 2000	0.83

The correlation between HGHYX and FBTAX shifts across timeframes, from 0.71 (1 year) to 0.83 (all time), reflecting how their relationship changes across market environments.

Return for Risk

HGHYX vs. FBTAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HGHYX

HGHYX Risk / Return Rank: 22
HGHYX Sharpe Ratio Rank: 22
HGHYX Sortino Ratio Rank: 23
HGHYX Omega Ratio Rank: 20
HGHYX Calmar Ratio Rank: 26
HGHYX Martin Ratio Rank: 19

FBTAX

FBTAX Risk / Return Rank: 62
FBTAX Sharpe Ratio Rank: 50
FBTAX Sortino Ratio Rank: 47
FBTAX Omega Ratio Rank: 40
FBTAX Calmar Ratio Rank: 93
FBTAX Martin Ratio Rank: 81

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HGHYX vs. FBTAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Hartford Healthcare Fund (HGHYX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HGHYX	FBTAX	Difference
Sharpe ratio Return per unit of total volatility	1.36	2.10	-0.74
Sortino ratio Return per unit of downside risk	2.05	2.87	-0.82
Omega ratio Gain probability vs. loss probability	1.24	1.34	-0.10
Calmar ratio Return relative to maximum drawdown	1.91	5.18	-3.27
Martin ratio Return relative to average drawdown	5.30	15.20	-9.90
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HGHYX vs. FBTAX - Sharpe Ratio Comparison

The current HGHYX Sharpe Ratio is 1.36, which is lower than the FBTAX Sharpe Ratio of 2.10. The chart below compares the historical Sharpe Ratios of HGHYX and FBTAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HGHYX	FBTAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.36	2.10	-0.74
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	0.40	-0.26
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.49	0.43	+0.06
Sharpe Ratio (All Time) Calculated using the full available price history	0.59	0.31	+0.29

Drawdowns

HGHYX vs. FBTAX - Drawdown Comparison

The maximum HGHYX drawdown since its inception was -42.58%, smaller than the maximum FBTAX drawdown of -63.55%. Use the drawdown chart below to compare losses from any high point for HGHYX and FBTAX.

Drawdown Indicators

	HGHYX	FBTAX	Difference
Max Drawdown Largest peak-to-trough decline	-42.58%	-63.55%	+20.97%
Max Drawdown (1Y) Largest decline over 1 year	-10.82%	-8.91%	-1.91%
Max Drawdown (3Y) Largest decline over 3 years	-22.60%	-32.86%	+10.26%
Max Drawdown (5Y) Largest decline over 5 years	-25.42%	-36.51%	+11.09%
Max Drawdown (10Y) Largest decline over 10 years	-28.51%	-38.82%	+10.31%
Current Drawdown Current decline from peak	-6.22%	-8.91%	+2.69%
Average Drawdown Average peak-to-trough decline	-7.64%	-21.22%	+13.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.90%	3.03%	+0.87%

Volatility

HGHYX vs. FBTAX - Volatility Comparison

The current volatility for The Hartford Healthcare Fund (HGHYX) is 3.74%, while Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a volatility of 7.10%. This indicates that HGHYX experiences smaller price fluctuations and is considered to be less risky than FBTAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HGHYX	FBTAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.74%	7.10%	-3.36%
Volatility (6M) Calculated over the trailing 6-month period	10.57%	16.71%	-6.14%
Volatility (1Y) Calculated over the trailing 1-year period	14.84%	22.10%	-7.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.81%	23.47%	-7.66%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.73%	24.42%	-6.69%

HGHYX vs. FBTAX - Expense Ratio Comparison

Both HGHYX and FBTAX have an expense ratio of 1.00%.

Dividends

HGHYX vs. FBTAX - Dividend Comparison

HGHYX's dividend yield for the trailing twelve months is around 2.98%, more than FBTAX's 1.47% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBTAX Fidelity Advisor Biotechnology Fund Class A	1.47%	1.45%	6.00%	1.15%	0.00%	20.12%	8.37%	6.77%	2.50%	0.00%	0.00%	5.36%
HGHYX The Hartford Healthcare Fund	2.98%	2.88%	4.74%	0.00%	0.83%	8.86%	10.56%	10.72%	7.15%	4.67%	9.23%	13.39%

Frequently Asked Questions

Can I hold both HGHYX and FBTAX in my portfolio?

HGHYX and FBTAX have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HGHYX or FBTAX?

FBTAX has higher volatility (7.10%) compared to HGHYX (3.74%). In terms of maximum drawdown, HGHYX dropped -42.58% vs FBTAX's -63.55%.

Which has better risk-adjusted returns?

FBTAX currently has the higher Sharpe Ratio (2.10 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.